Jennison Associates LLC Spring Works Therapeutics, Inc. Transaction History

Jennison Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$53.3 - $75.84 $34.4 Million - $49 Million	-645,521 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$62.66 - $88.26 $20.8 Million - $29.3 Million	331,862 Added 105.8%	645,521 $41 Million
Q2 2021 Aug 12, 2021	BUY	$67.45 - $85.63 $8.67 Million - $11 Million	128,574 Added 69.47%	313,659 $25.8 Million
Q1 2021 May 11, 2021	BUY	$65.1 - $93.59 $12 Million - $17.3 Million	185,085 New	185,085 $13.6 Million
Q2 2020 Aug 06, 2020	SELL	$22.98 - $48.57 $5.83 Million - $12.3 Million	-253,654 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$20.44 - $41.21 $45,111 - $90,950	2,207 Added 0.88%	253,654 $6.85 Million
Q4 2019 Feb 07, 2020	BUY	$17.74 - $39.52 $22,104 - $49,241	1,246 Added 0.5%	251,447 $9.68 Million
Q3 2019 Nov 08, 2019	BUY	$18.8 - $27.82 $4.7 Million - $6.96 Million	250,201 New	250,201 $5.42 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.6B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.